Cite
RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine.
MLA
Illingworth, M. A., et al. “RYR1-Related Congenital Myopathy with Fatigable Weakness, Responding to Pyridostigimine.” Neuromuscular Disorders : NMD, vol. 24, no. 8, Aug. 2014, pp. 707–12. EBSCOhost, https://doi.org/10.1016/j.nmd.2014.05.003.
APA
Illingworth, M. A., Main, M., Pitt, M., Feng, L., Sewry, C. A., Gunny, R., Vorstman, E., Beeson, D., Manzur, A., Muntoni, F., & Robb, S. A. (2014). RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine. Neuromuscular Disorders : NMD, 24(8), 707–712. https://doi.org/10.1016/j.nmd.2014.05.003
Chicago
Illingworth, M A, M Main, M Pitt, L Feng, C A Sewry, R Gunny, E Vorstman, et al. 2014. “RYR1-Related Congenital Myopathy with Fatigable Weakness, Responding to Pyridostigimine.” Neuromuscular Disorders : NMD 24 (8): 707–12. doi:10.1016/j.nmd.2014.05.003.